Health Screenings Every Man Should Have: A Clinical Checklist by Age

Men are statistically less likely than women to seek preventive care, and the gap is not small. The clinical consequence is that conditions that are easily detected and managed when caught early, low testosterone, cardiovascular disease, prediabetes, sleep apnea, and prostate changes among them, often progress undetected until they are symptomatic and harder to treat. By the time a man finally walks in with a complaint, the window for the easiest interventions has often already closed.

The screenings that actually change male health outcomes are not all the same at 32 as they are at 52. The categories shift, the priorities shift, and the cost of skipping a particular check changes with each decade. This guide walks through what matters at each stage, what is most often missed, and how to put a coherent screening plan together rather than reacting to whatever your provider happened to order at your last visit.

In Your 30s: Building a Metabolic Baseline

The annual visit in your 30s is less about catching active disease, which is statistically uncommon at this stage, and more about establishing the baseline numbers that will define what is normal for you personally. These become the comparison points for detecting meaningful change in your 40s. A 30-year-old with a testosterone level of 650 ng/dL who is at 480 ng/dL at age 45 is showing meaningful decline, even though both numbers fall inside the reference range. Without the baseline, that decline cannot be detected with the same confidence.

The screens that should be in place at every annual visit through your 30s include blood pressure, fasting lipid panel (LDL, HDL, triglycerides), HbA1c, fasting glucose, and fasting insulin together (which allows HOMA-IR calculation that detects insulin resistance well before fasting glucose alone becomes abnormal). Comprehensive metabolic panel and CBC round out the basic blood work. Thyroid evaluation should include not just TSH but also free T3, free T4, and TPO antibodies; TSH alone misses early autoimmune thyroid disease that can produce fatigue, weight changes, and mood symptoms for years before TSH itself becomes abnormal. Vitamin D (25-OH vitamin D) is worth measuring given how common deficiency is in adults. Testosterone (total, free, and SHBG) at age 30 to 35 establishes the baseline that makes future hormone evaluation interpretable.

In Your 40s: When Hormonal Decline Becomes Clinically Significant

Testosterone declines at approximately 1 to 2 percent per year after age 30 per the Massachusetts Male Aging Study. By the mid-40s, many men with genetic predisposition, chronic stress, shift work, sleep apnea, or significant weight gain will have testosterone levels that are clinically low and symptomatic. The 40s are also when cardiovascular risk escalates, as the cumulative effects of a decade of borderline metabolic health start to compound. The 40s are when the price of not paying attention in the 30s starts to come due.

The screenings to add at this stage build on the 30s baseline rather than replace it:

• Full hormone panel: testosterone (total, free, SHBG), estradiol, LH, FSH, prolactin, and DHEA-S. If any of these were not measured in the 30s, the 40s are the critical time to start.
• Cardiovascular risk calculation: using the lipid panel, blood pressure, smoking history, glucose status, and age. For intermediate-risk patients, a coronary artery calcium (CAC) score is the most precise stratification tool currently available, and it changes statin and lifestyle decisions in a way that no other test does at this stage.
• PSA baseline: men at average risk should begin PSA discussion at 50, but a baseline value in the early 40s makes later changes more interpretable. Men with a first-degree relative who had prostate cancer should start the conversation earlier, typically at 40 to 45. The same earlier-start guidance applies to Black men, who have a higher incidence of prostate cancer and often more aggressive disease.
• Sleep apnea screening: standard Epworth Sleepiness Scale plus clinical history. Sleep apnea is significantly underdiagnosed in men, directly suppresses testosterone, and substantially raises cardiovascular risk. Heavy snoring, witnessed apnea episodes, morning headaches, and daytime sleepiness despite adequate sleep duration all warrant a low-threshold home sleep study.

In Your 50s and Beyond: Cancer, Bone, and Continued Cardiac Monitoring

The 50s shift the screening focus toward cancer detection, bone health, and continued cardiovascular surveillance. None of the earlier screens go away, the metabolic and hormone work continue, but new screens are added in this decade because the conditions they detect become statistically meaningful at this age.

Colon cancer screening is the largest addition. The American Cancer Society updated guidelines recommend colonoscopy beginning at age 45 for average-risk men, with follow-up every 10 years for normal results. High-risk men, those with a family history of colorectal cancer or adenomatous polyps, require earlier and more frequent screening. Colonoscopy not only finds early cancers but also removes precancerous polyps before they can progress, which is why the procedure reduces colorectal cancer mortality more than detection alone would predict.

PSA screening should be a regular conversation by 50 for average-risk men. Annual or biennial PSA with clinical context, not just isolated numbers, provides the most actionable surveillance. A rising trend over time is more meaningful than any single value, which is part of why establishing earlier baselines pays off.

Bone density (DEXA) is often dismissed as a women’s test, but men over 70, or men over 50 with risk factors (low testosterone, glucocorticoid use, smoking, low BMI, history of fragility fracture) should have a baseline DEXA. Testosterone deficiency directly accelerates bone loss in men, and the consequences of fragility fractures are as significant for men as for women. The mortality after a hip fracture in older men is actually higher than in women.

Men 65 to 75 who have ever smoked should have a one-time abdominal aortic aneurysm screening ultrasound, which is a quick, low-cost test that catches a condition with significant mortality if missed. Continued cardiovascular monitoring through this decade is also non-negotiable, including periodic lipid review and clinical reassessment of statin candidacy if not already on therapy.

How Often to Repeat Each Screening

Annual physicals can give the impression that everything is on a once-a-year schedule, but most screening tests have their own appropriate intervals. Knowing the intervals helps both with planning and with knowing when results are still considered current.

Lab work (lipid panel, fasting insulin, HbA1c, thyroid, vitamin D, hormones) is generally annual through the 30s and 40s, with hormone panels worth repeating every 6 to 12 months once therapy is started or if a notable change is suspected. Blood pressure should be checked at every visit. Cardiovascular risk should be recalculated annually, with a coronary artery calcium score worth considering once at intermediate risk and repeating only if the clinical picture changes meaningfully. Colonoscopy is every 10 years for normal results, more frequently if polyps are found or family history warrants it. PSA cadence is annual to biennial in men actively monitoring it. DEXA after a normal scan can wait several years unless risk factors change. Sleep studies are not periodic screens; they are ordered when symptoms suggest the need.

What to Do If You’re Behind on Men’s Health Screenings

Many men reading this will recognize that they are behind, sometimes by a decade or more. The temptation in that situation is either to do everything at once in a panic or to keep putting it off because the list feels overwhelming. Neither response is useful. The pragmatic approach is to start with the highest-yield screens and add the rest over the following six to twelve months.

The single highest-yield first step for most men over 40 who have skipped preventive care is a comprehensive blood panel: lipid panel, fasting insulin and glucose, HbA1c, full thyroid, vitamin D, and a complete hormone panel. That single morning blood draw produces enough information to identify the conditions that most often drive symptoms in this age group. Cardiovascular risk calculation and a sleep apnea questionnaire can happen at the same visit. Cancer screening (colonoscopy at 45 and PSA conversation at 50) and bone density (in the 50s and 60s with risk factors) can be scheduled separately and do not need to be done the same week.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on wellness, hormone optimization, and preventive medicine. In-person care in Sugar Hill, GA, and telehealth for Georgia residents.